Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Dr. Shah on Improving the Benefit of Immunotherapy in Gastric/GEJ Cancer

December 6th 2019

Manish A. Shah, MD, discusses ongoing efforts to improve immunotherapy in gastric and gastroesophageal junction cancer.

Next Steps for Wnt Research in Colorectal Cancer

December 6th 2019

Luke Dow, PhD, discusses the next steps for researching the Wnt pathway in colorectal cancer.

FDA Panel to Review Olaparib Application in Metastatic Pancreatic Cancer

December 6th 2019

The FDA has scheduled an Oncologic Drugs Advisory Committee hearing for December 17, 2019, to discuss a supplemental new drug application for olaparib tablets as a maintenance treatment of adult patients with deleterious or suspected deleterious BRCA-mutant metastatic pancreatic adenocarcinoma whose disease has not progressed on frontline platinum-based chemotherapy.

Dr. Hidalgo Medina on Treatment Considerations in Pancreatic Cancer

December 5th 2019

Manuel Hidalgo Medina, MD, PhD, discusses treatment considerations in pancreatic cancer.

Dr. Corcoran on Promising Combination Strategies With Immunotherapy in mCRC

December 5th 2019

Ryan B. Corcoran, MD, PhD, discusses promising combination strategies with immunotherapy in metastatic colorectal cancer.

Dr. Ocean on Impact of the PRODIGE 24/CCTG PA.6 Trial in Pancreatic Cancer

December 3rd 2019

Allyson Ocean, MD, discusses the impact of the phase III PRODIGE 24/CCTG PA.6 trial on patients with pancreatic cancer.

Dr. Benson on the Ongoing Research With Immunotherapy in mCRC

December 3rd 2019

Al B. Benson, MD, professor of medicine, Hematology and Oncology, Northwestern University Feinberg School of Medicine, discusses ongoing research with immunotherapy in metastatic colorectal cancer (mCRC).

Genomic Era Trials Drive Discovery

December 2nd 2019

Innovative clinical trials designed to exploit the explosion of data on the drivers of cancer are demonstrating value as tools to explore potential signals of efficacy across tumor types, according to oncology experts. These studies have become a feature of the drug discovery landscape in oncology and are likely to remain part of the fabric of clinical research in the genomic era.

Evolving HCC Treatment Paradigm: Combinations and Sequencing

December 2nd 2019

Advanced HCC: Guiding Second-Line Therapy With AFP

December 2nd 2019

Second-Line Use of I/O Therapy for Advanced HCC

December 2nd 2019

Second-Line Therapy for Advanced HCC: The CELESTIAL Trial

December 2nd 2019

Second-Line Therapy for Advanced HCC: The RESOURCE Trial

December 2nd 2019

Future of Frontline Combination Therapy in Advanced HCC

December 2nd 2019

Advanced HCC: Trial Data for Frontline Combination Therapy

December 2nd 2019

Frontline I/O Therapy for HCC: Results From CheckMate459

December 2nd 2019

Selecting a Frontline TKI for Advanced HCC

December 2nd 2019

Newly Diagnosed Advanced HCC: Frontline Therapy Overview

December 2nd 2019

ASTRO Presents First Guideline for RT in Pancreatic Cancer

November 30th 2019

Recent strides in systemic treatment approaches and the broader application of stereotactic radiation led the American Society for Radiation Oncology to issue its first guideline regarding radiation therapy in patients with pancreatic cancer.

Dr. Patel on Sequencing Therapy in Rectal Cancer

November 28th 2019

Timil Patel, MD, discusses an optimal sequencing strategy in rectal cancer.